News | December 06, 2007

Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011

December 7, 2007 - Driven by an aging population and continued advances in biotechnology, the worldwide surgical and trauma wound treatment market is expected to post a compound annual growth rate of 5.5 percent and grow to $7 billion by 2011, according to “Wound Care Markets, Volume III: Surgical and Trauma Wounds,” a new report released this week by Kalorama Information.

With more than 100,000 surgeries performed daily in the U.S. alone and millions performed annually worldwide, surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, and the aging world population has created increased demand for all types of surgical intervention, particularly cardiovascular, orthopedic, urological, and dermatological procedures.

As a result, the reports states the surgical and trauma wound treatment market grew nearly 70 percent between 2001 and 2006 with conventional, mature products generating the majority of sales. Although the market has experienced its ups and downs - due primarily to demographic conditions, cost constraint measures, and product availability - Kalorama Information projects the market will continue to expand, with growth for the forecasted period likely coming from new therapies and emerging technologies that decrease healing times, provide cost savings, and improve patient care.

“In order to remain competitive, manufacturers must have a clear insight into physician usage patterns and recent market movements to make perceptive business decisions,” said Mary Anne Crandall, the report’s author. “Competitors that offer traditional mature products must look for ways to incorporate advanced wound care products for speeding healing with their existing products or to improve the existing products significantly to remain competitive with emerging technologies.”

The study focuses on the world market for six product categories: wound closure, anti-infectives, surgical and trauma wound management, moist dressing, biological dressings, and miscellaneous treatments. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry.

For more information: www.kaloramainformation.com/Wound-Care-Edition-1399493, www.MarketResearch.com

Related Content

News | October 01, 2008
October 2, 2008 - Canica Design Inc., said its new SutureSafe is now available.
News | July 17, 2008
July 18, 2008 – 3M Health Care and Greystone Pharmaceuticals Inc.
News | June 11, 2008
June 12, 2008 – Nevada Cancer Institute’s (NVCI) Diagnostic Imaging Department said it has been approved to participa
Technology | May 15, 2008
Results of an independent clinical study conducted by U.S.
News | May 14, 2008
May 15, 2008 - Apria Healthcare Group Inc.
News | May 04, 2008
May 5, 2008 – ConvaTec said its Flexi-Seal Fecal Management System (FMS), a temporary containment device indicated fo
News | May 01, 2008
May 2, 2008 - Results of an independent clinical study conducted by U.S.
News | April 30, 2008
May 1, 2008 – Covidien today introduced the VascuSeal Vascular Sealant System throughout Europe and in select Middle
News | April 27, 2008
April 28, 2008 - Derma Sciences said today the FDA has given clearance to another dressing in the MEDIHONEY product l
Overlay Init